Sarah S. Lee, MD
Seattle Cancer Care Alliance
University of Washington School of Medicine
Fred Hutchinson Cancer Research Center
Multiple myeloma, amyloidosis, Waldenström's macroglobulinemia
I’m grateful for the long-term relationships I develop with patients and families; together we work toward common goals, navigate unforeseen setbacks and celebrate milestones.”
Why do you focus on treating patients with multiple myeloma and similar disorders?
Before going to medical school, I got a job in the clinical research department of a cancer center. I worked with an investigator who was testing new drug therapies for multiple myeloma, a type of cancer that affects cells in the immune system. It was the first time I had conducted research in a clinical setting, where I got to interact with patients and witness up close how scientific advances can directly impact people. The experience lit a fire that inspired me to continue working with this population of patients and to keep looking for opportunities to improve treatment options. It’s really exciting to see how quickly this area of medicine continues to evolve and to see patients with multiple myeloma and similar disorders living longer and enjoying a better quality of life.
Specialties and clinical expertise
The branch of medicine a provider practices and their areas of focus
I am a hematologist-oncologist who specializes in the care of patients with plasma cell disorders. Plasma cells are a type of white blood cell that live in the bone marrow and help the body fight infection. Sometimes these cells don’t work as they should, developing into cancers such as multiple myeloma.
Before joining SCCA, I completed a fellowship in hematology-oncology at the Cleveland Clinic. My background also includes experience in researching novel therapies for multiple myeloma, amyloidosis and other plasma cell disorders. What drew me to SCCA was the opportunity to participate in clinical research and to embrace a collaborative approach to medicine. It’s not any single physician taking care of you; there’s a whole team of experts working together to help you navigate the ups and downs of your diagnosis.
What’s it like to work with you?
By the time some patients with plasma cell disorders see me, they have been feeling ill for a long period of time without understanding why or receiving a diagnosis, which can be a frustrating experience. From the moment we first meet, I focus on laying the groundwork for a trusting, positive relationship where you feel comfortable asking questions and talking openly about your concerns. I’m interested in learning about what your medical journey has been like so far and what’s important to you as an individual. I’m grateful for the long-term relationships I develop with patients and families; together we work toward common goals, manage unforeseen setbacks and celebrate milestones.
University of California, Berkeley
St. George's University School of Medicine
Rutgers New Jersey Medical School, Internal Medicine
Cleveland Clinic, Hematology-Oncology
Medical Oncology, 2017, American Board of Internal Medicine